Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
about
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.Counter-flow suggests transport of dantrolene and 5-OH dantrolene by the organic anion transporters 2 (OAT2) and 3 (OAT3).In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models.
P2860
Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@ast
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@en
type
label
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@ast
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@en
prefLabel
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@ast
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@en
P2093
P1476
Identification of new MRP4 inh ...... ughput bioluminescence screen.
@en
P2093
Denise M T Yu
Leanna Cheung
Tim W Failes
Zillan Neiron
P304
P356
10.1016/J.BCP.2014.11.006
P407
P577
2014-11-22T00:00:00Z